Abstract
The estrogenic activities of chemicals for dental and similar use were tested by a reporter gene assay (yeast two-hybrid system) and an estrogen/estrogen receptor (ER-α) competition binding assay (fluorescence polarization system). Among the 10 chemicals [bisphenol-A (BPA), bis-2-hydroxypropyl methacrylate (Bis-GMA), triethylene glycol dimethacrylate (TEGDMA), methyl methacrylate (MMA) and 2-hydroxyethyl methacrylate (HEMA), dibutyl phthalate (DBP), n-butyl benzyl phthalate (BBP), n-butyl phthalyl n-butyl glycolate (BPBG), di-2-ethylhexyl phthalate (DEHP), and di-2-ethylhexyl adipate (DOA)], which were diluted with DMSO to concentrations ranging from 5 × 10-7 to 5 × 10-3M, and 17β-estradiol (E2) as a positive control, BPA and BBP showed estrogenic activity in these two assays, while the remaining eight chemicals did not at the concentrations tested. Additional data, together with in vivo and epidemiological examinations, are required. Such investigations should also provide information on the validity of these methods for testing the estrogenic activity of chemicals.
Similar content being viewed by others
References
N. OLEA, R. PULGAR, P. PEREZ, F. OLEA, A. RIVAS, A. NOVILLO, V. PEDRAZA, A. M. SOTO and C. SONNENSCHEIN, Environ. Health Perspect. 104 (1996) 298–305.
D. FELDMAN, Endocrinology 138 (1997) 1777–1779.
R. STEINMETZ, N. G. BROWN, D. L. ALLEN, R. M. BIGSBY, and N. BEN-JONATHAN Endocrinology 138 (1997) 1780–1786.
J. NISHIKAWA, K. SAITO, J. GOTO, F. DAKEYAMA, M. MATSUO and T. NISHIHARA Toxcol. Appl. Pharmacol. 154 (1999) 76–83.
R. BOLGER, T. E. WIESE, K. EVRIN, S. NESTICH and W. CHECOVICH Environ. Health Perspect. 106 (1998) 551–557.
H. R. STANLEY, R. L. BOWEN and J. FOLIO, J. Dent. Res. 58 (1979) 1507–1517.
C. T. HANKS, S. E. STRAWN, J. C. WATAHA and R. C. CRAIG, ibid. 70 (1991) 1450–1455.
E. YOSHII, J. Biomed. Mater. Res. 37 (1997) 517–524.
A. J. CARMICHAEL, J. J. GIBSON and A. W. WALLS, Br. Dent. J. 183 (1997) 297–298.
M. VILLALOBOS, N. OLEA, J. A. BROTONS, M. F. OLEA, J. M. RUIZ DE ALMODOVAR and V. PEDRAZA, Environ. Health Perspect. 103 (1995) 844–850.
P. PEREZ, R. PULGAR, F. OLEA, M. VILLALOBOS, A. RIVAS, M. METZLER, V. PEDRAZA and N. OLEA, ibid. 106 (1998) 167–174.
D. NATHASON, M. GHULMAN, N. ASHAYERI and L. CHOU, in “Proceeding of the 77th general session of the IADR”, March 1999, p. 194.
A. MARIOTTI, K. J. SODERHOLM and S. JOHNSON, Euro. J. Oral Sci. 106 (1998) 1022–1027.
J. E. ROUTLEDGE and J. P. SUMPTER, J. Biol. Chem. 272 (1997) 3280–3288.
W. L. GUESS, J. JACOB and J. AUTIAN, Drug Intelligence 1 (1967) 120.
J. A. THOMAS and M. J. THOMAS, CRC Crit. Rev. Toxicol 13 (1984) 283–317.
P. W. ALBRO, Biochem. Toxicol. 8 (1986) 73–119.
J. AUTIAN, Environ. Health Perspect. 4 (1973) 3–26.
R. M. SHARP, J. S. FISHER, M. M. MILLAR, S. JOBLING and J. P. SUMPTER, ibid. 103 (1995) 1136–1143.
M. KAWAGUCHI, H. TAKAHASHI, T. FUKUSHIMA, Y. INOUE, T. HABU and K. MIYAZAKI, J. J. Dent. Mater. Special 32 (1998) 47.
C. A. HARRIS, P. HENTTU, M. G. PARKER and J. P. SUMPTER, Environ. Health Perspect. 105 (1997) 802–811.
Illinois EPA disrupters strategy (1997).
S. JOBLING, T. REYNOLDS, R. WHITE, M. G. PARKER and J. P. SUMPTER, Environ. Health Perspect. 103 (1995) 582–587.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hashimoto, Y., Moriguchi, Y., Oshima, H. et al. Estrogenic activity of chemicals for dental and similar use in vitro. Journal of Materials Science: Materials in Medicine 11, 465–468 (2000). https://doi.org/10.1023/A:1013009006522
Issue Date:
DOI: https://doi.org/10.1023/A:1013009006522